T1	Participants 182 238	patients undergoing coronary artery bypass graft surgery
T2	Participants 648 730	12,855 patients, of whom 7,967 (62.0%) were treated preoperatively with β-blockers
T3	Participants 538 618	patients who received preoperative β-blockers with those of patients who did not
T4	Participants 1896 1933	coronary artery bypass graft surgery.
